MEDIZEN HUMANCARE Inc.

A236340

KR7236340006

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-09 pm EDT			5-day change	1st Jan Change
5,600 ^KRW	+0.18%		+3.90%	+40.00%

2023	MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI
2023	MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	CI

MEDIZEN HUMANCARE Inc. announced that it has received KRW 999.992 million in funding

December 19, 2021

On December 20, 2021, MEDIZEN HUMANCARE Inc. closed the transaction.

Latest news about MEDIZEN HUMANCARE Inc.

MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-29	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.96 billion in funding from Daesang Well Life Co., Ltd.	23-01-19	CI
PT Indo Medizen Sehat announced that it has received KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-25	CI
PT Indo Medizen Sehat announced that it expects to receive KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.	22-08-24	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 3.469998 billion in funding	22-02-10	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 999.992 million in funding	21-12-19	CI
MEDIZEN HUMANCARE Inc. announced that it has received KRW 1.499988 billion in funding	21-12-14	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 999.992 million in funding	21-12-09	CI
MEDIZEN HUMANCARE Inc. announced that it expects to receive KRW 1.499988 billion in funding	21-12-06	CI
HPio Co., Ltd. and BM International Holdings Co., Ltd. acquired 7.4% stake in MEDIZEN HUMANCARE Inc. for KRW 1.4 billion.	20-11-08	CI
Medizen Humancare Inc Co., Ltd announced that it has received KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-23	CI
Medizen Humancare Inc Co., Ltd announced that it expects to receive KRW 1.999982 billion in funding from Woori Bank Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm	18-10-15	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 1 billion in funding	17-02-16	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 1 billion in funding	17-02-15	CI
Kiwoom Growth 15th Secondary Investment Fund managed by Kiwoom Investment Co., Ltd. acquired 1.96% stake in Medizen Humancare Co.,Ltd. for KRW 650 million.	17-01-23	CI
An individual and a company acquired 2.5% stake in Medizen Humancare Co.,Ltd. from K2 Liquidity Solution Fund managed by K2 Investment Partners LLC.	17-01-18	CI
Medizen Humancare Co.,Ltd. announced that it has received KRW 2.5 billion in funding	17-01-15	CI
Medizen Humancare Co.,Ltd. announced that it expects to receive KRW 2.5 billion in funding	17-01-12	CI
Samsung Pharmaceutical Co., Ltd. completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd.	15-10-04	CI
Samsung Pharmaceutical Co., Ltd. agreed to sell 17.13% stake in Medizen Humancare Co.,Ltd. for KRW 2 billion.	15-08-31	CI

Medizen Humancare Inc Co., Ltd is a Korea-based company mainly engaged in the provision of disease prediction services. The Company is involved in the provision of disease prediction services named My-Genome Check (M-CHECK). In addition, it is involved in the conduction of research projects, as well as the manufacturing and sale of saliva kits.

Sector

Biotechnology & Medical Research

Calendar

01:00am - Investor Meeting

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
MEDIZEN HUMANCARE INC.	+40.00%	9.39M
EXACT SCIENCES CORPORATION	-42.02%	7.91B
GUARDANT HEALTH, INC.	+11.13%	3.68B
IOVANCE BIOTHERAPEUTICS, INC.	-0.92%	2.25B
BGI GENOMICS CO., LTD.	-21.69%	1.97B
VERACYTE, INC.	-24.10%	1.6B
CAREDX, INC	+24.33%	777M
SEEGENE, INC.	-10.48%	687M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-28.78%	514M
CURIOX BIOSYSTEMS CO., LTD	-1.29%	290M

Bio Diagnostics & Testing

MEDIZEN HUMANCARE Inc.

Equities

A236340

KR7236340006

Biotechnology & Medical Research

MEDIZEN HUMANCARE Inc. announced that it has received KRW 999.992 million in funding

Latest news about MEDIZEN HUMANCARE Inc.

Chart MEDIZEN HUMANCARE Inc.

Company Profile

Sector Bio Diagnostics & Testing